DAMILA PINA BETANCOURT: Open Payments
NPI 1629799333 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,070 in 52 payments from 16 companies in 2025. Trend: 2023 $237 · 2024 $551 · 2025 $1,070
Food & beverage: $1,070
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $281 |
| GlaxoSmithKline, LLC. | 7 | $145 |
| Novartis Pharmaceuticals Corporation | 6 | $114 |
| Phathom Pharmaceuticals, Inc. | 7 | $107 |
| Novo Nordisk Inc | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Amgen Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $40 |
| Lilly USA, LLC | 2 | $39 |
Products named: GEMTESA, TRELEGY ELLIPTA, VOQUEZNA, LEQVIO, VERQUVO, EVENITY, LINZESS, MOUNJARO.
Industry payments across FL — which companies pay providers there.
